Artiva Biotherapeutics, Inc. (ARTV)
Nasdaq: ARTV · Biological Products, (No Diagnostic Substances) · San Diego, CA · filing with the SEC since 2020
Who runs Artiva Biotherapeutics, Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Aslan Fred
Chief Executive Officer. First filing Jul 2024, latest Nov 3, 2026, 10 filings in all.
Officers reporting now
8
of 20 people with a filing in the last fifteen months
Directors reporting now
12
23 people on the record since 2024
Officerssales are open-market, Nov 3, 2025 to Nov 3, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Aslan Fred | Chief Executive Officer | Jul 2024 | Nov 3, 2026 | 8 · $2.1M |
| Bush Jennifer | COO, CLO, Compliance Officer | Jul 2024 | Nov 3, 2026 | 4 · $300,000 |
| Banerjee Subhashis | Chief Medical Officer | Apr 2025 | Nov 3, 2026 | 6 · $200,000 |
| Horan Christopher | Chief Tech Operations Officer | Jul 2024 | Nov 3, 2026 | 4 · $300,000 |
| Miralles Gines Diego | President & Head of R&D | Jul 2024 | Sep 11, 2026 | none |
| Raymon Heather | SVP, Research and Development | Jul 2024 | May 19, 2026 | 1 · $0.00 |
| Huston Thad Allen | Chief Financial Officer | Feb 2026 | Mar 10, 2026 | none |
| Krishnamohan Neha | Chief Financial Officer | Jul 2024 | Nov 17, 2025 | none |
Directorssales are open-market, Nov 3, 2025 to Nov 3, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Baker Daniel G. | director | Jan 2025 | Sep 14, 2026 | none |
| Daniels Brian | director | Jul 2024 | Sep 14, 2026 | none |
| Hougen Elizabeth L | director | Jul 2024 | Sep 14, 2026 | none |
| Kolchinsky Peter | director | Jul 2024 | Sep 14, 2026 | none |
| Moore Alison | director | Oct 2024 | Sep 14, 2026 | none |
| Ra Capital Healthcare Fund LP | director | Jul 2024 | Sep 14, 2026 | none |
| Ra Capital Management, L.P. | director | Jul 2024 | Sep 14, 2026 | none |
| Ra Capital Nexus Fund III, L.P. | director | Jul 2024 | Sep 14, 2026 | none |
| Ra Capital Nexus Fund, L.P. | director | Jul 2024 | Sep 14, 2026 | none |
| Shah Rajeev M. | director | Jul 2024 | Sep 14, 2026 | none |
| Sorg Elaine K. | director | Feb 2026 | Sep 14, 2026 | none |
| Stoppel Laura | director | Jul 2024 | Sep 14, 2026 | none |
Owners of more than 10% of a classsales are open-market, Nov 3, 2025 to Nov 3, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Gc Cell Corp | 10% owner | Jul 2024 | May 28, 2026 | none |
| Gc Corp. | 10% owner | Jul 2024 | May 28, 2026 | none |
Earlier names on the record15, newest filing first
Graef Thorsten · officer · last filing Feb 20255am Opportunities II (Gp), LLC · 10% owner · last filing Jul 20245am Opportunities II, L.P. · 10% owner · last filing Jul 20245am Partners Vi, LLC · 10% owner · last filing Jul 20245am Ventures Vi, L.P. · 10% owner · last filing Jul 2024Parmar Kush · 10% owner · last filing Jul 2024Schwab Andrew J. · 10% owner · last filing Jul 2024Huh Yong-Jun · director · last filing Jul 2024Adelman Robert J · 10% owner · last filing Jul 2024Goodman Corey S · 10% owner · last filing Jul 2024Venbio Global Strategic Fund III, L.P. · 10% owner · last filing Jul 2024Venbio Global Strategic Gp III, L.P. · 10% owner · last filing Jul 2024Venbio Global Strategic Gp III, Ltd · 10% owner · last filing Jul 2024Wellington Biomedical Innovation Master Investors (Cayman) I L.P. · 10% owner · last filing Jul 2024Bessen Laura · director · last filing Jul 2024
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.